Oncotelic Therapeutics Investor Presentation
Oncotelic Therapeutics presented its Partitioned Literature Aggregation (PLA) framework at the 22nd Drug Discovery Strategic Summit. The presentation detailed the use of AI and literature analysis to identify a four-gene mTOR signature for hepatocellular carcinoma and outlined plans for an AI-driven research environment targeting 100 billion protein-related vectors.